SavedAdd your journal

Journals / Türk Kardiyoloji Derneği Arşivi / 2010 / Cilt: 38 - Sayı: 4

Primary percutaneous coronary intervention in patients admitted with cardiogenic shock and ST-elevation myocardial infarction: prognosis and predictors of in-hospital mortality

Kardiyojenik şokla başvuran ST yükselmeli miyokart enfarktüslü hastalarda primer perkütan koroner girişim: Prognoz ve hastane içi mortalitenin belirleyicileri

Mehmet ERGELEN
Emre AKKAYA
Şükrü AKYÜZ
Ersin YILDIRIM
Duygu ERSAN
Deniz DEMİRC
Hüseyin UYAREL
Nurten SAYAR
Tuna TEZEL
Ceyhan TÜRKKAN
Pages
250–257
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Procedural success rate was substantially lower in nonsurvivors (39% vs. 84.4%; p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: We investigated the efficacy and outcome of primary percutaneous coronary intervention (PCI) in patients admitted with cardiogenic shock and ST-elevation myocardial infarction (STEMI).Study design: We reviewed 91 consecutive patients (66 males, 25 females; mean age 61±11 years) treated with primary PCI for cardiogenic shock due to STEMI.
📊
Key Findings & Data:The patients were classified into two groups depending on the presence (n=59, 64.8%) or absence (n=32, 35.2%) of in-hospital mortality.Results: Hospital nonsurvivors were older (mean age 62.7±11.1 vs. 57.7±11.4 years; p=0.04) and exhibited higher frequencies of diabetes mellitus (DM), renal failure, and history of myocardial infarction.
💡
Conclusion & Impact:Procedural success rate was substantially lower in nonsurvivors (39% vs. 84.4%; p
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: We investigated the efficacy and outcome of primary percutaneous coronary intervention (PCI) in patients admitted with cardiogenic shock and ST-elevation myocardial infarction (STEMI).Study design: We reviewed 91 consecutive patients (66 males, 25 females; mean age 61±11 years) treated with primary PCI for cardiogenic shock due to STEMI. All clinical, angiographic data, and in-hospital and long-term outcomes were collected. The patients were classified into two groups depending on the presence (n=59, 64.8%) or absence (n=32, 35.2%) of in-hospital mortality.Results: Hospital nonsurvivors were older (mean age 62.7±11.1 vs. 57.7±11.4 years; p=0.04) and exhibited higher frequencies of diabetes mellitus (DM), renal failure, and history of myocardial infarction. Multi-vessel disease (p=0.004) and circumflex artery involvement (p=0.03) were more frequent and the rates of tirofiban administration (p=0.02) and stenting (p=0.007) were lower in nonsurvivors. Procedural success rate was substantially lower in nonsurvivors (39% vs. 84.4%; p

Özet

Amaç: Bu çalışmada, kardiyojenik şokla başvuran ST yükselmeli miyokart enfarktüslü (STYME) hastalarda primer perkütan koroner girişimin (PKG) etkinliği ve sonuçları değerlendirildi.Ça­lış­ma pla­nı: Çalışmaya STYME’ye bağlı kardiyojenik şok nedeniyle primer PKG uygulanan ardışık 91 hasta (66 erkek, 25 kadın; ort. yaş 61±11) alındı. Tüm klinik ve anjiyografik verilerle birlikte hastane içi ve uzun dönem sonuçlar geriye dönük olarak toplandı. Olgular, hastane içi dönemde mortalite gelişen (n=59, %64.8) ve gelişmeyen (n=32, %35.2) hastalar olarak iki gruba ayrıldı.Bul­gu­lar: Hastane içi mortalite gelişen grupta yaş (ort. 62.7±11.1 ve 57.7±11.4; p=0.04) ve diabetes mellitus (DM), renal yetersizlik ve miyokart enfarktüsü öyküsü sıklığı daha yüksekti. Çoklu damar hastalığı (p=0.004) ve sirkumfleks arter tutulumu (p=0.03) mortalite gelişen grupta; tirofiban (p=0.02) ve stent kullanımı (p=0.007) sağkalım grubunda daha yüksek orandaydı. İşlem başarısı mortalite gelişen grupta anlamlı derecede düşük bulundu (%39 ve %84.4%; p

🔖

Cite This Article

ERGELEN, M., AKKAYA, E., AKYÜZ, Ş., YILDIRIM, E., ERSAN, D., DEMİRC, D., UYAREL, H., SAYAR, N., TEZEL, T., TÜRKKAN, C. (2022). Primary percutaneous coronary intervention in patients admitted with cardiogenic shock and ST-elevation myocardial infarction: prognosis and predictors of in-hospital mortality. Türk Kardiyoloji Derneği Arşivi, Cilt: 38 - Sayı: 4, 250–257. https://ajindex.com/articles/633256

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Hasdai D, Topol EJ, Califf RM, Berger PB, Holmes DR Jr. Cardiogenic shock complicating acute coronary syndromes. Lancet 2000;356:749-56
  2. Goldberg RJ, Gore JM, Thompson CA, Gurwitz JH. Recent magnitude of and temporal trends (1994-1997) in the incidence and hospital death rates of cardiogenic shock complicating acute myocardial infarction: the second national registry of myocardial infarction. Am Heart J 2001;141:65-72
  3. Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O’Keefe J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1993; 328:673-9
  4. Weaver WD, Simes RJ, Betriu A, Grines CL, Zijlstra F, Garcia E, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA 1997; 278:2093-8
  5. Califf RM, Bengtson JR. Cardiogenic shock. N Engl J Med 1994;330:1724-30
  6. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function measured and estimated glomerular filtration rate. N Engl J Med 2006;354:2473 83
  7. Tiefenbrunn AJ, Chandra NC, French WJ, Gore JM, Rogers WJ. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol 1998;31:1240-5
  8. Berger AK, Radford MJ, Krumholz HM. Cardiogenic shock complicating acute myocardial infarction in elderly patients: does admission to a tertiary center improve survival? Am Heart J 2002;143:768-76
  9. Tarantini G, Ramondo A, Napodano M, Bilato C, Isabella G, Razzolini R, et al. Myocardial perfusion grade and survival after percutaneous transluminal coronary angioplasty in patients with cardiogenic shock. Am J Cardiol 2004;93:1081-5
  10. Giri S, Mitchel J, Azar RR, Kiernan FJ, Fram DB, McKay RG, et al. Results of primary percutaneous transluminal coronary angioplasty plus abciximab with or without stenting for acute myocardial infarction complicated by cardiogenic shock. Am J Cardiol 2002; 89:126-31
  11. Lee L, Bates ER, Pitt B, Walton JA, Laufer N, O’Neill WW. Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock. Circulation 1988; 78:1345-51
  12. Lee L, Erbel R, Brown TM, Laufer N,